
The FDA approved daraxonrasib for pancreatic cancer, cleared zanidatamab-based regimens for HER2-positive gastric cancer, and more.
Shaji K. Kumar, MD, professor of medicine, Mayo Clinic, discusses the management of newly diagnosed patients with multiple myeloma.
Shaji K. Kumar, MD, professor of medicine, Mayo Clinic, discusses the management of newly diagnosed patients with multiple myeloma.
It is important to make the right diagnosis, says Kumar, especially when deciding when to start treatment for these patients.
Secondly, it is imperative that patients are properly risk-stratified—guidelines of which have been updated in the past few years. This gives a better sense of which patients will do well and which patients will not, Kumar adds.






